Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and efficacy of different doses of remimazolam for anesthesia induction in elderly off-pump CABG
ChiCTR2600130110Phase 4Not yet recruiting
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam in coronary arteriosclerosis (3 arms), sponsored by General Hospital of the Northern Theater Command. Primary endpoint: Changes in mean arterial pressure at intubation. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR2600130110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600130110.